Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma-a prospective multicenter observational study pointing out new unmet needs.

Damen, Pim J J; Verhoeff, Joost J C

Damen, Pim J J; Verhoeff, Joost J C.

Afiliación

Damen PJJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Verhoeff JJC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Transl Cancer Res ; 12(3): 688-691, 2023 Mar 31.

Article en En | MEDLINE | ID: mdl-37033340

Palabras clave

Checkpoint inhibitors; Response Evaluation Criteria in Solid Tumors (RECIST); abscopal response; oligoprogression; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google